Evidence map›Paper›PMID 34164910›Full record

ArticleJournal of cellular and molecular medicine2021

METTL3/N6-methyladenosine/ miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-κB pathway activation.

Erpeng Liu, Lei Lv, Yonghao Zhan, Yuan Ma, Jinjin Feng, Yulin He, Yibo Wen, Yanping Zhang, Qingsong Pu, Fengping Ji and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Role of mZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Erpeng LiuDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.ORCID 0000-0002-2793-2516
Lei LvDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yonghao ZhanDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yuan MaDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jinjin FengDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yulin HeDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yibo WenDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yanping ZhangDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Qingsong PuDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Fengping JiDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xinghuan YangDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Jian Guo WenDepartment of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhengzhou University · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal fibrosis induced by urinary tract obstruction is a common clinical occurrence; however, effective treatment is lacking, and a deeper understanding of the mechanism of renal fibrosis is needed. Previous studies have revealed that miR-21 impacts liver and lung fibrosis progression by activating the SPRY1/ERK/NF-kB signalling pathway. However, whether miR-21 mediates obstructive renal fibrosis through the same signalling pathway has not been determined. Additionally, studies have shown that N6-methyladenosine (m

Indexed as

Adaptor Proteins, Signal TransducingAdenosineAnimalsCell LineDisease Models, AnimalFemaleFibrosisHumansInflammationKidney DiseasesMembrane ProteinsMethyltransferasesMiceMice, Inbred C57BLMicroRNAsMitogen-Activated Protein Kinase 3Adaptor Proteins, Signal TransducingAdenosineMapk3 protein, mouseMembrane ProteinsMethyltransferasesMettl3 protein, mouseMicroRNAsMIRN21 microRNA, mouseMitogen-Activated Protein Kinase 3NF-kappa BN-methyladenosineSpry1 protein, mouseMETTL3miR-21-5pN6-methyladenosine (m6A)renal fibrosisSpry1/ERK/NF-κBurinary tract obstruction

Identifiers

PMID34164910
PMCPMC8358893
OpenAlexW3173718495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.